Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

Market Cap	28.24B
Revenue (ttm)	8.71B
Net Income (ttm)	468.07M
Shares Out	1.49B
EPS (ttm)	0.32
PE Ratio	59.37
Forward PE	15.16
Dividend	0.25 (1.32%)
Ex-Dividend Date	Jul 10, 2025

Volume	27,807,129
Average Volume	29,386,526
Open	18.76
Previous Close	18.89
Day's Range	18.74 - 19.14
52-Week Range	13.49 - 27.97
Beta	0.27
RSI	44.23
Earnings Date	Oct 31, 2025

About SHA:600521

Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as high-density polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade services. The company was founded in 1989 and is headquartered in Linhai, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 9,065
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600521

Financial Performance

In 2024, SHA:600521's revenue was 9.55 billion, an increase of 14.91% compared to the previous year's 8.31 billion. Earnings were 1.12 billion, an increase of 34.74%.